Edimer Pharmaceuticals is categorized under in Cambridge, MA and active since 2009.
Edimer Pharmaceuticals was established in 2009, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Neil Kirby, Chief Executive Officer at the company’s single location by writing to 55 Cambridge Parkway # 101, Cambridge, Massachusetts MA 02142 or by phoning (617) 758-4300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Edimer Pharmaceuticals |
| Contact Person: | Neil Kirby, Chief Executive Officer |
| Address: | 55 Cambridge Parkway # 101, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 758-4300 |
| Website Address: | edimerpharma.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 4461100 |
| Share This Business: |
Edimer Pharmaceuticals was started in 2009 to provide professional under the SIC code 2834 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Neil Kirby, Chief Executive Officer for inquiries that concern Edimer Pharmaceuticals by calling the company number (617) 758-4300, as your correspondence is most welcome. Additionally, the physical location of the single location of Edimer Pharmaceuticals can be found at the coordinates 42.362985,-71.086639 as well as the street address 55 Cambridge Parkway # 101 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Edimer Pharmaceuticals’s website at edimerpharma.com and engage with its social media outlets through on Twitter and on Facebook.